ATE415149T1 - Dosierungsform eines pulveragglomerates - Google Patents

Dosierungsform eines pulveragglomerates

Info

Publication number
ATE415149T1
ATE415149T1 AT03020466T AT03020466T ATE415149T1 AT E415149 T1 ATE415149 T1 AT E415149T1 AT 03020466 T AT03020466 T AT 03020466T AT 03020466 T AT03020466 T AT 03020466T AT E415149 T1 ATE415149 T1 AT E415149T1
Authority
AT
Austria
Prior art keywords
dosage form
powder agglomerate
agglomerate
powder
dosage
Prior art date
Application number
AT03020466T
Other languages
English (en)
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE415149(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE415149T1 publication Critical patent/ATE415149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03020466T 1997-03-20 1998-03-16 Dosierungsform eines pulveragglomerates ATE415149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20

Publications (1)

Publication Number Publication Date
ATE415149T1 true ATE415149T1 (de) 2008-12-15

Family

ID=25232603

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03020466T ATE415149T1 (de) 1997-03-20 1998-03-16 Dosierungsform eines pulveragglomerates
AT98911423T ATE284677T1 (de) 1997-03-20 1998-03-16 Herstellung von pulveragglomeraten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98911423T ATE284677T1 (de) 1997-03-20 1998-03-16 Herstellung von pulveragglomeraten

Country Status (25)

Country Link
EP (3) EP1393721B1 (de)
JP (5) JP3901738B2 (de)
KR (1) KR100386055B1 (de)
CN (3) CN1149076C (de)
AR (1) AR011986A1 (de)
AT (2) ATE415149T1 (de)
AU (1) AU741783B2 (de)
CA (3) CA2481868C (de)
CL (1) CL2011000050A1 (de)
CZ (1) CZ295460B6 (de)
DE (2) DE69840277D1 (de)
DK (2) DK1393721T3 (de)
ES (2) ES2234102T3 (de)
HU (2) HU230274B1 (de)
ID (1) ID24472A (de)
IL (1) IL131640A0 (de)
MY (1) MY120725A (de)
NO (1) NO328062B1 (de)
NZ (1) NZ337443A (de)
PL (3) PL204480B1 (de)
PT (2) PT1393721E (de)
SK (1) SK284919B6 (de)
TW (1) TWI221778B (de)
WO (1) WO1998041193A1 (de)
ZA (1) ZA982254B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
WO2001013885A1 (en) * 1999-08-20 2001-03-01 Norton Healthcare Ltd. Method to produce powders for pulmonary or nasal administration
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (de) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1654001A2 (de) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medikamente zur inhalation mit steroiden und einem betamimetikum
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
US7318925B2 (en) 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CA2540005A1 (en) * 2003-09-26 2005-04-07 Schering Corporation Pulmonary disease treatment
JP2007509941A (ja) * 2003-10-28 2007-04-19 グラクソ　グループ　リミテッド ラクトース無水物を用いる吸入医薬製剤およびその投与方法
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
JP2012524815A (ja) * 2009-04-24 2012-10-18 シェーリング コーポレイション 乾燥粉末吸引器において有用な凝集体配合物
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
PT2560611T (pt) * 2010-04-21 2018-02-07 Chiesi Farm Spa Processo para proporcionar partículas com cargas eletrostáticas reduzidas
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
MX392636B (es) 2014-10-31 2025-03-24 Glaxosmithkline Ip Dev Ltd Formulacion en polvo.
KR102794286B1 (ko) * 2016-01-08 2025-04-09 테론 파마슈티칼즈, 인크. 7-아조니아바이사이클로[2.2.1]헵탄 유도체의 건조 분말 흡입기 조성물
CN117122585A (zh) * 2023-07-27 2023-11-28 宁波诺丁汉大学 一种通过振动混合制备干粉吸入团聚物处方制剂方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ES2044710T3 (es) * 1990-01-29 1994-01-01 Ciba Geigy Ag Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina.
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
DK0613371T3 (da) * 1991-12-18 2002-05-13 Astrazeneca Ab Ny kombination af formoterol og budesonid
DK0674533T3 (da) * 1992-12-18 1999-09-27 Schering Corp Inhalator for medikamenter i pulverform
PT721331E (pt) * 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
EP1283035A3 (de) * 1994-12-22 2003-03-19 AstraZeneca AB Parathyroidhormon enthaltende therapeutische Zubereitung zur Inhalation

Also Published As

Publication number Publication date
PL208480B1 (pl) 2011-05-31
HK1021323A1 (en) 2000-06-09
CN1903179A (zh) 2007-01-31
ID24472A (id) 2000-07-20
PL204480B1 (pl) 2010-01-29
JP2014037446A (ja) 2014-02-27
DK0969816T3 (da) 2005-03-14
HU0600845D0 (en) 2007-01-29
NO994519D0 (no) 1999-09-17
SK128099A3 (en) 2000-06-12
DK1393721T3 (da) 2009-03-30
EP0969816A1 (de) 2000-01-12
CA2282360C (en) 2004-11-09
ES2316681T3 (es) 2009-04-16
PT1393721E (pt) 2009-02-02
JP2006152000A (ja) 2006-06-15
ATE284677T1 (de) 2005-01-15
ES2234102T3 (es) 2005-06-16
PL335742A1 (en) 2000-05-08
AU741783B2 (en) 2001-12-06
NO328062B1 (no) 2009-11-13
CA2282360A1 (en) 1998-09-24
SK284919B6 (sk) 2006-02-02
CA2481868A1 (en) 1998-09-24
EP0969816B1 (de) 2004-12-15
JP3901738B2 (ja) 2007-04-04
JP2010275316A (ja) 2010-12-09
PL192441B1 (pl) 2006-10-31
CN1149076C (zh) 2004-05-12
CL2011000050A1 (es) 2011-06-24
KR20010005520A (ko) 2001-01-15
CN100548277C (zh) 2009-10-14
CZ295460B6 (cs) 2005-08-17
KR100386055B1 (ko) 2003-06-09
CN1552310A (zh) 2004-12-08
CA2706634C (en) 2012-10-23
CA2706634A1 (en) 1998-09-24
NZ337443A (en) 2001-04-27
DE69828155D1 (de) 2005-01-20
DE69828155T2 (de) 2005-12-22
JP2000510478A (ja) 2000-08-15
HUP0002029A2 (hu) 2000-11-28
MY120725A (en) 2005-11-30
AU6537898A (en) 1998-10-12
HU226671B1 (en) 2009-06-29
EP2036544B1 (de) 2016-12-28
EP1393721B1 (de) 2008-11-26
HU230274B1 (hu) 2015-11-30
IL131640A0 (en) 2001-01-28
JP2010248260A (ja) 2010-11-04
JP5523240B2 (ja) 2014-06-18
HK1061359A1 (en) 2004-09-17
CN1257423A (zh) 2000-06-21
CA2481868C (en) 2010-06-15
EP1393721A1 (de) 2004-03-03
WO1998041193A1 (en) 1998-09-24
NO994519L (no) 1999-11-19
HUP0002029A3 (en) 2001-02-28
TWI221778B (en) 2004-10-11
EP2036544A1 (de) 2009-03-18
CN100518718C (zh) 2009-07-29
ZA982254B (en) 1998-09-17
AR011986A1 (es) 2000-09-13
PT969816E (pt) 2005-04-29
DE69840277D1 (de) 2009-01-08
CZ323399A3 (cs) 2000-02-16

Similar Documents

Publication Publication Date Title
ATE415149T1 (de) Dosierungsform eines pulveragglomerates
EE04707B1 (et) Pulberinhalaator
FI942196L (fi) Jauheinhalaattori
FI962520A7 (fi) Jauheinhalaattori
DE69625036D1 (de) Volumetrische Pulverzuführvorrichtung
ZA987551B (en) Solid pharmaceutical dosage forms
DE69428743D1 (de) Trockenpulverinhalator
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
FI964595L (fi) Pulveri-inhalaattori
DE69331635D1 (de) Pulverinhalator
DE59810370D1 (de) Pulverlack
DE69830154D1 (de) Pharmazeutische zusammensetzungen
FI955441L (fi) Jauheinhalaattori
DE59509148D1 (de) Puderbestäubungsgerät
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
NO20003182L (no) FremgangsmÕte for inhalering av pulverstoffer
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
ID19844A (id) Komponen tumbukan
AU5343498A (en) Thiophene compounds and medicinal use thereof
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
KR940018782U (ko) 과립형 분말 흡입기
KR940024237U (ko) 과립형 분말 흡입기
FI980265A7 (fi) Suihkujauhin
SE9703829D0 (sv) Powder inhaleri
KR970000526U (ko) 분말 공급장치

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1393721

Country of ref document: EP